(EGRX)—For reasons that are unclear to me, more and more biotech companies are failing to file SEC reports on time; here’s the latest instance: https://www.globenewswire.com/news-release/2024/04/12/2862382/0/en/Eagle-Pharmaceuticals-Announces-Receipt-of-Notification-of-Deficiency-from-Nasdaq-Regarding-Requirement-to-Timely-File-Annual-Report-on-Form-10-K.html EGRX has not yet filed either the 2023 10-K or the 3Q23 10-Q!